These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 23027189)
21. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex. Rastogi N; Goh KS; Bryskier A Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850 [TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex. Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732 [TBL] [Abstract][Full Text] [Related]
23. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing]. Gui J; Wang F; Hong CY; Li JL; Liang J Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731 [TBL] [Abstract][Full Text] [Related]
30. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients. Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254 [TBL] [Abstract][Full Text] [Related]
31. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview. Kumar C; Shrivastava K; Singh A; Chauhan V; Varma-Basil M Int J Mycobacteriol; 2021; 10(3):293-300. PubMed ID: 34494569 [TBL] [Abstract][Full Text] [Related]
32. Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome. Kwak N; Whang J; Yang JS; Kim TS; Kim SA; Yim JJ Chest; 2021 Feb; 159(2):517-523. PubMed ID: 32712225 [TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States. Hunkins JJ; de-Moura VC; Eddy JJ; Daley CL; Khare R Diagn Microbiol Infect Dis; 2023 Mar; 105(3):115882. PubMed ID: 36610383 [TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method. Udou T J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338 [TBL] [Abstract][Full Text] [Related]
36. Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections. Banaschewski B; Verma D; Pennings LJ; Zimmerman M; Ye Q; Gadawa J; Dartois V; Ordway D; van Ingen J; Ufer S; Stapleton K; Hofmann T J Cyst Fibros; 2019 Sep; 18(5):714-720. PubMed ID: 31138497 [TBL] [Abstract][Full Text] [Related]
37. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306 [TBL] [Abstract][Full Text] [Related]
38. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance. Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842 [TBL] [Abstract][Full Text] [Related]